KALA KALA BIO INC
FollowCMN (common), issuer CIK 1479419
13 managers (14 13F filers) reported a position in KALA shares at 2026-06-30, 701,204 shares in all. 14 filers opened a position and 0 filers sold out during the quarter.
- Managers
- 13
- 13F filers
- 14
- New
- 14
- Added
- 0
- Reduced
- 0
- Sold out
- 0
- Shares held by filers
- 701,204
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Labkowski Nachum
966,991 shares, 5% in a 13G as of 2026-10-14,0002123249-26-000002
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Labkowski Nachum reported 966,991 KALA shares, 5% of the class, as of 2026-10-14, in a 13G filed 2026-10-19. 0002123249-26-000002
Accepted , ingested